Pseudo-buried Barrett’s post radiofrequency ablation for Barrett’s esophagus, with or without prior endoscopic resection

Background and study aim: In our experience, biopsies from small residual islands of nonburied Barrett’s mucosa after radiofrequency ablation (RFA) are occasionally reported by pathologists to contain “buried Barrett’s” upon histological evaluation, despite the fact that these islands of columnar mucosa were visible endoscopically. The aim of this study was to evaluate the frequency of buried Barrett’s in biopsies obtained from small residual Barrett’s islands ( < 5 mm) sampled post-RFA, compared with biopsies from normal neosquamous epithelium.

Patients and methods: Biopsies obtained from normal-appearing neosquamous epithelium and from small Barrett’s islands ( < 5 mm) in 69 consecutive Barrett’s patients treated with RFA were evaluated for the presence of buried columnar mucosa.

Results: A total of 2515 biopsies were obtained from neosquamous epithelium during follow-up post-RFA. Buried glands were found in 0.1 % of biopsies from endoscopically normal neosquamous epithelium. However, when small islands of columnar mucosa were biopsied, buried glands were detected in 21 % of biopsies.

Conclusion: To avoid accidental sampling of small islands resulting in a false-positive histological diagnosis of buried Barrett’s, thorough inspection should be performed before obtaining biopsies during post-RFA follow-up.

• References

• 1 Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semi Radial Oncol 2007; 17: 2-9
• 2 Gondrie JJ, Pouw RE, Sondermeijer CM et al. Stepwise circumferential and focal ablation of Barrett’s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 2008; 40: 359-369
• 3 Gondrie JJ, Pouw RE, Sondermeijer CM et al. Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 2008; 40: 370-379
• 4 Pouw RE, Wirths K, Eisendrath P et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol 2010; 8: 23-29
• 5 Van Vilsteren FG, Pouw RE, Seewald S et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 2011; 60: 765-773
• 6 Hage M, Siersema PD, van Dekken H et al. 5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett oesophagus: a randomised trial. Gut 2004; 53: 785-790
• 7 Manner H, May A, Miehlke S et al. Ablation of nonneoplastic Barrett’s mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation. Am J Gastroenterol 2006; 101: 1762-1769
• 8 Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc 2003; 58: 183-181
• 9 Gossner L, Stolte M, Sroka R et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid. Gastroenterology 1998; 114: 448-455
• 10 Peters FP, Kara MA, Rosmolen WD et al. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in Barrett esophagus after endoscopic resection. Endoscopy 2005; 37: 418-424
• 11 Fleischer DE, Overholt BF, Sharma VK et al. Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc 2008; 68: 867-876
• 12 Shaheen NJ, Sharma P, Overholt BF et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 2009; 360: 2277-2288
• 13 Lyday WD, Corbett FS, Kuperman DA et al. Radiofrequency ablation of Barrett’s esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy 2010; 42: 272-278
• 14 Sampliner RE, Fass R. Partial regression of Barrett’s oesophagus – an inadequate endpoint. Am J Gastroenterol 1933; 12: 2092-2094
• 15 Van Laethem JL, Peny MO, Salmon I et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett’s oesophagus. Gut 2000; 46: 574-577
• 16 Mino-Kenudson M, Ban S, Ohana M et al. Buried dysplasia and early adenocarcinoma arising in Barrett esophagus after Porfimer-photodynamic therapy. Am J Surg Pathol 2007; 31: 403-409
• 17 Hornick JL, Blount PL, Sanchez CA et al. Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett’s esophagus. Am J Surg Pathol 2005; 29: 372-380
• 18 Pouw RE, Gondrie JJ, Rygiel AM et al. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett’s esophagus containing neoplasia. Am J Gastroenterol 2009; 104: 1366-1373
• 19 Overholt BF, Dean PJ, Galanko JA et al. Does ablative therapy for Barrett esophagus affect the depth of subsequent esophageal biopsy as compared with controls?. J Clin Gastroenterol 2010; 44: 676-681
• 20 Shaheen NJ, Peery AF, Overholt BF et al. Biopsy depth after radiofrequency ablation of dysplastic Barrett’s esophagus. Gastrointest Endosc 2010; 72: 490-496
• 21 Biddlestone LR, Barham CP, Wilkinson SP et al. The histopathology of treated Barrett’s esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy. Am J Surg Pathol 1998; 22: 239-245
• 22 Sarbia M, Donner A, Gabbert HE. Histopathology of the gastroesophageal junction: a study on 36 operation specimens. Am J Surg Pathol 2002; 26: 1207-1212
• 23 Phoa KN, Pouw RE, van Vilsteren FG et al. Remission of Barrett’s esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology 2013; 145: 96-104